ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia (AML)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00510133
Recruitment Status : Completed
First Posted : August 1, 2007
Last Update Posted : August 13, 2014
Sponsor:
Information provided by (Responsible Party):
Asterias Biotherapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2011
  Actual Study Completion Date : August 2014